Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2229Neoplasms 2031Lung Neoplasms 1094Colorectal Neoplasms 1033Prostatic Neoplasms 892Carcinoma, Non-Small-Cell Lung 751Carcinoma, Hepatocellular 672Stomach Neoplasms 606Pancreatic Neoplasms 599Head and Neck Neoplasms 433Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Urinary Bladder Neoplasms 289Leukemia, Myeloid, Acute 276Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 251Disease 241Recurrence 225Glioma 217Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Observational × Metastatic Hormone-sensitive Prostate Cancer × Clear all
NCT07031258 2025-06-22

Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

Nanfang Hospital, Southern Medical University

Not yet recruiting
50 enrolled
Genitourinary

Metastatic Hormone-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡